FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAXâ"¢ System. The addition of these new assays to the BD MAXâ"¢ System portfolio enables clinical l ...

Core Insights - Anbio Biotechnology is actively participating in three major international exhibitions to expand its global presence in human and veterinary healthcare [1][5] - The company aims to meet the increasing demand for faster, more accurate, and decentralized testing solutions through its diversified portfolio and expanding global network [2][5] - Anbio's mission focuses on reshaping diagnostics through collaboration, innovation, and accessibility, as stated by its CEO [3][5] Company Strategy - Anbio has product registrations in over 100 countries and is pursuing a global strategy of innovation, collaboration, and commercialization [5][7] - The company is seeking distribution partners, research collaborators, and strategic investors to enhance diagnostic access and co-develop market-specific solutions [6][7] Product Offerings - Anbio's diagnostic portfolio includes Fluorescence Immunoassay (FIA) Systems, Dry Chemistry Analyzers, Rapid Test Kits, Molecular Diagnostic Systems, and a Veterinary Diagnostics Suite [8] - The FIA Systems support 90 test items for rapid and quantitative detection across various clinical areas [8] - Dry Chemistry Analyzers are designed for essential biochemical testing at the point of care, ideal for decentralized settings [8] - The Molecular Diagnostic System includes LAMP-based Rapid Mdx System and real-time RT-PCR reagents, enabling faster nucleic acid detection [8] - The Veterinary Diagnostics Suite integrates various diagnostic methods to support companion animal health needs [8]